Drug Co. Eiger Can Probe Lender On Foiled PIPE Deal Fallout

By Alex Wittenberg · May 29, 2024, 7:27 PM EDT

Eiger BioPharmaceuticals received a Texas bankruptcy judge's approval Wednesday to collect documents from lender Innovatus Life Sciences tied to what the rare-disease drugmaker called Innovatus's decision to "manufacture" a default under...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Eiger BioPharmaceuticals, Inc.

Case Number

Court

Texas Northern

Nature of Suit

Date Filed

April 01, 2024

Recent Articles By Alex

November 01, 2024
Buca Di Beppo Gets OK On $27M Sale To Main Street Capital
October 30, 2024
Implant Maker Exactech Can Tap $85M DIP After Cutting Fees
October 29, 2024
MVP: Latham's George Davis
October 29, 2024
PE-Owned Implant Maker Plagued By Lawsuits Hits Ch. 11
October 28, 2024
Ex-Judge Can't Shield Bank Docs; Tupperware Agrees To Sale
October 25, 2024
Incora To Exit Ch. 11 With Uptier Fight Headed To Appeal
October 23, 2024
American Tire Hits Ch. 11 Again With $1.9B Of Debt, Sale Plan
October 21, 2024
Keeping Track Of The Catholic Diocese Bankruptcy Cases
October 16, 2024
Big Lots Protections For $760M Bid Draw US Trustee Protest
October 15, 2024
Sacklers Say Opioid Claims Can't Undo Purdue Transfers